Senior Correspondent, London
Ben's Feed
May 20, 2013
May 20, 2013
May 17, 2013
May 16, 2013
May 16, 2013
May 16, 2013
May 16, 2013

AstraZeneca accelerates cancer drug testing

LONDON, May 16 (Reuters) – AstraZeneca has enrolled
the first patient into a final-stage clinical trial of a new
drug for a rare type of leukaemia as the group’s new CEO
delivers on a promise to accelerate its oncology programmes.

Britain’s second-biggest drugmaker said on Thursday the
Phase III clinical trial would test moxetumomab pasudotox in
patients with hairy cell leukaemia who have not responded to or
have relapsed after standard therapy.
May 15, 2013
May 14, 2013
May 14, 2013
Previous1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15Next

    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."

    • More from Ben

      Twitter:
      @reutersBenHir

    • Follow Ben

      RSS feed icon Subscribe to all posts via RSS (What is RSS?)